Regulatory variation in a TBX5 enhancer leads to isolated congenital heart disease.

Recent studies have identified the genetic underpinnings of a growing number of diseases through targeted exome sequencing. However, this strategy ignores the large component of the genome that does not code for proteins, but is nonetheless biologically functional. To address the possible involvement of regulatory variation in congenital heart diseases (CHDs), we searched for regulatory mutations impacting the activity of TBX5, a dosage-dependent transcription factor with well-defined roles in the heart and limb development that has been associated with the Holt-Oram syndrome (heart-hand syndrome), a condition that affects 1/100 000 newborns. Using a combination of genomics, bioinformatics and mouse genetic engineering, we scanned ∼700 kb of the TBX5 locus in search of cis-regulatory elements. We uncovered three enhancers that collectively recapitulate the endogenous expression pattern of TBX5 in the developing heart. We re-sequenced these enhancer elements in a cohort of non-syndromic patients with isolated atrial and/or ventricular septal defects, the predominant cardiac defects of the Holt-Oram syndrome, and identified a patient with a homozygous mutation in an enhancer ∼90 kb downstream of TBX5. Notably, we demonstrate that this single-base-pair mutation abrogates the ability of the enhancer to drive expression within the heart in vivo using both mouse and zebrafish transgenic models. Given the population-wide frequency of this variant, we estimate that 1/100 000 individuals would be homozygous for this variant, highlighting that a significant number of CHD associated with TBX5 dysfunction might arise from non-coding mutations in TBX5 heart enhancers, effectively decoupling the heart and hand phenotypes of the Holt-Oram syndrome.

[1]  P. Broderick,et al.  The 14q22.2 colorectal cancer variant rs4444235 shows cis-acting regulation of BMP4 , 2012, Oncogene.

[2]  Noboru Jo Sakabe,et al.  Transcriptional enhancers in development and disease , 2012, Genome Biology.

[3]  G. Wang,et al.  Tbx20 regulates a genetic program essential to adult mouse cardiomyocyte function. , 2011, The Journal of clinical investigation.

[4]  J. Shendure,et al.  Exome sequencing as a tool for Mendelian disease gene discovery , 2011, Nature Reviews Genetics.

[5]  M. Nóbrega,et al.  Alterations in TCF7L2 expression define its role as a key regulator of glucose metabolism. , 2011, Genome research.

[6]  Raymond K. Auerbach,et al.  A User's Guide to the Encyclopedia of DNA Elements (ENCODE) , 2011, PLoS biology.

[7]  Aibin He,et al.  Co-occupancy by multiple cardiac transcription factors identifies transcriptional enhancers active in heart , 2011, Proceedings of the National Academy of Sciences.

[8]  Milena B. Furtado,et al.  Loss of Cited2 causes congenital heart disease by perturbing left-right patterning of the body axis. , 2011, Human molecular genetics.

[9]  David P Bick,et al.  Making a definitive diagnosis: Successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease , 2011, Genetics in Medicine.

[10]  Nathaniel D. Heintzman,et al.  9p21 DNA variants associated with Coronary Artery Disease impair IFNγ signaling response , 2011, Nature.

[11]  Jingyuan Fu,et al.  Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction , 2010, Nature Genetics.

[12]  D. Altshuler,et al.  A map of human genome variation from population-scale sequencing , 2010, Nature.

[13]  M. Nóbrega,et al.  An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer. , 2010, Genome research.

[14]  Miguel Manzanares,et al.  Allelic Variation at the 8q23.3 Colorectal Cancer Risk Locus Functions as a Cis-Acting Regulator of EIF3H , 2010, PLoS genetics.

[15]  A. Visel,et al.  ChIP-Seq identification of weakly conserved heart enhancers , 2010, Nature Genetics.

[16]  Olle Melander,et al.  From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus , 2010, Nature.

[17]  Emily H Turner,et al.  Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome , 2010, Nature Genetics.

[18]  Kari Stefansson,et al.  Several common variants modulate heart rate, PR interval and QRS duration , 2010, Nature Genetics.

[19]  John M Westlund,et al.  Genome-wide discovery of human heart enhancers. , 2010, Genome research.

[20]  Christian Gieger,et al.  Genome-wide association study of PR interval , 2010, Nature Genetics.

[21]  C. Minguillon,et al.  Identification and characterisation of the developmental expression pattern of tbx5b, a novel tbx5 gene in zebrafish. , 2010, Gene expression patterns : GEP.

[22]  K. Pollard,et al.  Detection of nonneutral substitution rates on mammalian phylogenies. , 2010, Genome research.

[23]  A. Visel,et al.  Genomic Views of Distant-Acting Enhancers , 2009, Nature.

[24]  P. Broderick,et al.  The colorectal cancer risk at 18q21 is caused by a novel variant altering SMAD7 expression. , 2009, Genome research.

[25]  Emily H Turner,et al.  Targeted Capture and Massively Parallel Sequencing of Twelve Human Exomes , 2009, Nature.

[26]  K. Mesbah,et al.  Tbx3 Is Required for Outflow Tract Development , 2008, Circulation research.

[27]  J. Borlak,et al.  A loss-of-function mutation in the binding domain of HAND1 predicts hypoplasia of the human hearts. , 2008, Human molecular genetics.

[28]  B. Bruneau.  The developmental genetics of congenital heart disease , 2008, Nature.

[29]  J. Seidman,et al.  Corrigendum to “Tbx5-dependent rheostatic control of cardiac gene expression and morphogenesis” [Dev. Biol. 297 (2006) 566–586] , 2007 .

[30]  Mauro W. Costa,et al.  Mutations in cardiac T-box factor gene TBX20 are associated with diverse cardiac pathologies, including defects of septation and valvulogenesis and cardiomyopathy. , 2007, American journal of human genetics.

[31]  J. Bakkers,et al.  Early Endocardial Morphogenesis Requires Scl/Tal1 , 2007, PLoS genetics.

[32]  William Stafford Noble,et al.  Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project , 2007, Nature.

[33]  F. Sablitzky,et al.  lyl-1 and tal-1/scl, two genes encoding closely related bHLH transcription factors, display highly overlapping expression patterns during cardiovascular and hematopoietic ontogeny. , 2007, Gene expression patterns : GEP.

[34]  Kazuko Koshiba-Takeuchi,et al.  Tbx5-dependent rheostatic control of cardiac gene expression and morphogenesis. , 2006, Developmental biology.

[35]  M. Nóbrega,et al.  In vivo characterization of a vertebrate ultraconserved enhancer. , 2005, Genomics.

[36]  Ivan Ovcharenko,et al.  ECR Browser: a tool for visualizing and accessing data from comparisons of multiple vertebrate genomes , 2004, Nucleic Acids Res..

[37]  Ivan Ovcharenko,et al.  rVISTA 2.0: evolutionary analysis of transcription factor binding sites , 2004, Nucleic Acids Res..

[38]  Lior Pachter,et al.  VISTA: computational tools for comparative genomics , 2004, Nucleic Acids Res..

[39]  D. Haussler,et al.  Aligning multiple genomic sequences with the threaded blockset aligner. , 2004, Genome research.

[40]  Jonathan C. Cohen,et al.  GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5 , 2003, Nature.

[41]  B. Oostra,et al.  A long-range Shh enhancer regulates expression in the developing limb and fin and is associated with preaxial polydactyly. , 2003, Human molecular genetics.

[42]  T. Ogura,et al.  Tbx5 and Tbx4 trigger limb initiation through activation of the Wnt/Fgf signaling cascade , 2003, Development.

[43]  Denis Duboule,et al.  A Global Control Region Defines a Chromosomal Regulatory Landscape Containing the HoxD Cluster , 2003, Cell.

[44]  M. Fishman,et al.  The heartstrings mutation in zebrafish causes heart/fin Tbx5 deficiency syndrome. , 2002, Development.

[45]  J. Hoffman,et al.  The incidence of congenital heart disease. , 2002, Journal of the American College of Cardiology.

[46]  J. Schmitt,et al.  A Murine Model of Holt-Oram Syndrome Defines Roles of the T-Box Transcription Factor Tbx5 in Cardiogenesis and Disease , 2001, Cell.

[47]  J Jalife,et al.  Visualization and functional characterization of the developing murine cardiac conduction system. , 2001, Development.

[48]  M. Westerfield,et al.  The olfactory placodes of the zebrafish form by convergence of cellular fields at the edge of the neural plate. , 2000, Development.

[49]  K. Yutzey,et al.  Ventricular expression of tbx5 inhibits normal heart chamber development. , 2000, Developmental biology.

[50]  C. Drake,et al.  Vasculogenesis in the day 6.5 to 9.5 mouse embryo. , 2000, Blood.

[51]  B. Göttgens,et al.  An SCL 3' enhancer targets developing endothelium together with embryonic and adult haematopoietic progenitors. , 1999, Development.

[52]  J. Seidman,et al.  Chamber-specific cardiac expression of Tbx5 and heart defects in Holt-Oram syndrome. , 1999, Developmental biology.

[53]  M. Horb,et al.  Tbx5 is essential for heart development. , 1999, Development.

[54]  J. Seidman,et al.  Congenital heart disease caused by mutations in the transcription factor NKX2-5. , 1998, Science.

[55]  J. Seidman,et al.  Mutations in human TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndrome. , 1997, Nature genetics.

[56]  R. Kucherlapati,et al.  Mutations in human cause limb and cardiac malformation in Holt-Oram syndrome , 1997, Nature Genetics.

[57]  David I. Wilson,et al.  Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family , 1997, Nature Genetics.

[58]  Holger Karas,et al.  TRANSFAC: a database on transcription factors and their DNA binding sites , 1996, Nucleic Acids Res..

[59]  C. Kimmel,et al.  Stages of embryonic development of the zebrafish , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.

[60]  D G Wilkinson,et al.  Detection of messenger RNA by in situ hybridization to tissue sections and whole mounts. , 1993, Methods in enzymology.

[61]  E. Zackai,et al.  Deletions and microdeletions of 22q11.2 in velo-cardio-facial syndrome. , 1992, American journal of medical genetics.

[62]  C. Kimmel,et al.  Cell movements during epiboly and gastrulation in zebrafish. , 1990, Development.

[63]  A. Dalgleish.  The development of the septum primum relative to atrial septation in the mouse heart , 1976, Journal of morphology.

[64]  S. Oram,et al.  FAMILIAL HEART DISEASE WITH SKELETAL MALFORMATIONS , 1960, British heart journal.